Aterian, INC

Aterian, Inc. announces the completion of its asset sale to Trademark Global and a significant equity investment from David E. Lazar, alongside the establishment of a Contingent Value Rights Agreement.

Aterian, Inc. has adjourned its special meeting of stockholders to allow for additional voting time on a proposed asset sale, with the meeting reconvening on July 17, 2026.

Aterian, Inc. has declared a contingent value rights (CVR) dividend for shareholders following its planned asset sale and investment transaction.

Aterian, Inc. has officially regained compliance with Nasdaq's minimum bid price requirement, closing a period of concern for investors.

Aterian, Inc. announced a definitive agreement to sell its marquee brand portfolio to Trademark Global, LLC for $18 million and a strategic investment of $7 million from David Lazar.

Aterian, Inc. announced its strategic alternatives process is progressing with constructive discussions aimed at maximizing shareholder value, expecting another update in mid-April.

Aterian, Inc. has entered into a definitive agreement to sell its marquee brands for $18 million and secured a $7 million capital infusion to address liquidity concerns.

Aterian, Inc. reported a significant decline in net revenue and increased net losses for Q3 2025, citing macroeconomic pressures and new tariffs on Chinese imports.

Aterian, Inc. reported a significant decline in Q2 revenue and increased net loss, with its auditor raising substantial doubt about the company's ability to continue as a going concern.

Aterian Inc.'s Q1 2025 results reveal a revenue decrease alongside ongoing cost reduction initiatives and concerns about its ability to continue as a going concern.

Aterian Inc. reported a decrease in revenue for the third quarter of 2024, alongside a strategic shift focusing on profitable products and cost reductions.

Aterian, Inc. reported its second quarter 2024 results, highlighting a strategic shift towards profitable products and cost-cutting measures, alongside a decrease in revenue and a net loss.

Aterian, Inc. reported significantly increased net losses and negative operating cash flow for 2025, prompting a strategic alternatives review and raising substantial doubt about its ability to continue as a going concern.

Aterian, Inc. releases its 10-K filing for fiscal year 2024, detailing a strategic shift towards profitability amidst declining revenue and a challenging economic environment.

Aterian, Inc. has formalized its guidelines for insider trading and established a policy for recovering erroneously awarded compensation.

Director David E. Lazar acquired 1,750,000 shares of Series AA Convertible Preferred Stock in Aterian, Inc. for $3.5 million.

Aterian, Inc. Director William Kurtz was granted 40,394 shares of restricted common stock as compensation for his board service, increasing his beneficial ownership to 155,922 shares.

Aterian, Inc.'s Chief Financial Officer, Joshua O. Feldman, was granted 120,000 shares of restricted common stock for retention purposes.

Aterian, Inc.'s CEO, Arturo Rodriguez, was granted 50,000 shares of restricted common stock for retention purposes, effective January 23, 2026.

Aterian, Inc. Director Susan E. Lattmann was granted 25,555 shares of restricted common stock as compensation for her board service, increasing her direct beneficial ownership to 162,465 shares.

Aterian, Inc. Director Bari A. Harlam was granted 24,731 shares of restricted common stock on January 23, 2026, as compensation for Board service.

Aterian, Inc. has filed a Definitive Additional Materials (DEFA14A) proxy statement with the U.S. Securities and Exchange Commission.

Aterian, Inc. has scheduled its 2025 Annual Meeting of Stockholders for August 12, 2025, to address director elections, auditor ratification, and advisory votes on executive compensation, while also disclosing a significant reduction in net loss for fiscal year 2024.

Aterian, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) related to its upcoming shareholder meeting.

Aterian, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on August 16, 2024, to elect a director and ratify the appointment of its independent registered public accounting firm.